AI-Based Cognitive Rehabilitation Market Forecasts to 2034 – Global Analysis By Solution Type (AI Cognitive Therapy Platforms, Digital Rehabilitation Software, Neurofeedback Systems, Virtual Reality Rehabilitation, Robotic Rehabilitation Systems and Cognitive Assessment Platforms), Technology, Indication, End User and By Geography
According to Stratistics MRC, the Global AI-Based Cognitive Rehabilitation Market is accounted for $1.1 billion in 2026 and is expected to reach $3.6 billion by 2034 growing at a CAGR of 15.9% during the forecast period. AI-based cognitive rehabilitation refers to technology-driven therapeutic systems that employ artificial intelligence algorithms to assess, monitor, and restore cognitive functions impaired by neurological conditions, brain injuries, or neurodegenerative diseases. These platforms integrate machine learning models, computer vision, and natural language processing to deliver personalized rehabilitation exercises that adapt in real-time to patient performance and progress. The technology encompasses virtual reality environments, robotic assistance systems, neurofeedback interfaces, and digital assessment tools that enable clinicians to remotely track recovery trajectories and optimize intervention protocols for individual patients.
Market Dynamics:
Driver:
Rising neurological conditions
The rising global incidence of stroke, traumatic brain injury, and dementia is creating substantial demand for AI-based cognitive rehabilitation solutions. Aging populations in developed nations face increasing rates of cognitive impairment that strain traditional healthcare delivery capacity. Healthcare providers seek scalable technologies that extend specialist reach to underserved communities. Regulatory approvals for digital therapeutic interventions in neurological care accelerate clinical adoption. These demographic and systemic pressures generate sustained market expansion across hospital and home care settings.
Restraint:
High implementation costs
The high implementation costs and technical complexity of AI-based cognitive rehabilitation systems create significant barriers for smaller healthcare facilities and resource-constrained markets. Clinicians require extensive training to effectively interpret AI-generated assessments and adjust rehabilitation protocols. Integration with existing electronic health record systems remains technically challenging and expensive. These operational hurdles slow deployment timelines and limit market penetration beyond well-funded academic medical centers and specialized rehabilitation institutions.
Opportunity:
Home healthcare expansion
The expansion of home-based healthcare delivery models presents significant growth opportunities for AI-based cognitive rehabilitation providers. Remote monitoring capabilities enable continuous therapy outside clinical settings, improving patient adherence and outcomes while reducing healthcare system costs. Reimbursement frameworks increasingly recognize the value of remote therapeutic monitoring for chronic neurological conditions. Partnerships with home health agencies and family caregiver support programs create distribution channels that extend market reach beyond traditional facilities.
Threat:
Unvalidated alternatives
The emergence of generic cognitive training applications that lack clinical validation threatens to undermine market confidence in AI-based cognitive rehabilitation solutions. Consumer confusion between entertainment-oriented brain games and FDA-cleared therapeutic platforms creates pricing pressure and dilutes clinical credibility. Regulatory scrutiny of health claims for software-based interventions intensifies as the market expands. These factors complicate commercialization efforts for evidence-based rehabilitation technology developers.
Covid-19 Impact:
The COVID-19 pandemic severely disrupted in-person rehabilitation services while accelerating the adoption of remote AI-based cognitive therapy platforms. Hospital capacity constraints and infection control protocols forced the postponement of non-urgent neurological rehabilitation. Telehealth reimbursement expansions enabled the rapid deployment of remote cognitive assessment and training tools. Post-pandemic, hybrid care models that combine in-person and digital rehabilitation sessions have become standard practice.
The AI cognitive therapy platforms segment is expected to be the largest during the forecast period
The AI cognitive therapy platforms segment is expected to account for the largest market share during the forecast period, due to their comprehensive therapeutic capabilities and integration with clinical workflows. These platforms combine assessment, personalized exercise generation, and progress tracking within unified systems that support clinician decision-making. Healthcare institutions prefer all-in-one solutions that reduce technology procurement complexity. Established reimbursement codes for cognitive rehabilitation services further support the adoption of these clinically validated platforms.
The virtual reality segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the virtual reality segment is predicted to witness the highest growth rate, driven by its ability to create immersive, engaging rehabilitation environments that significantly improve patient motivation and adherence compared to traditional exercises. VR systems simulate real-world scenarios for practicing daily living skills in safe, controlled settings. Declining hardware costs and improved accessibility make virtual reality rehabilitation economically viable for broader patient populations. Clinical evidence demonstrating efficacy for stroke and trauma recovery accelerates adoption.
Region with largest share:
During the forecast period, the North America region is expected to hold the largest market share, due to advanced neurological research infrastructure and early regulatory approval pathways for digital therapeutic devices. The United States leads with substantial National Institutes of Health funding for brain injury research and established rehabilitation networks within the Veterans Health Administration. Major academic medical centers pioneer clinical validation studies that generate evidence supporting commercial adoption. Reimbursement frameworks increasingly cover remote therapeutic monitoring services.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapidly aging populations in China and Japan driving demand for neurological rehabilitation services. Government investment in smart healthcare initiatives supports technology adoption across public hospital networks. South Korea and Singapore lead in integrating robotic and virtual reality rehabilitation into standard clinical practice. The region's manufacturing capabilities reduce equipment costs, while growing health insurance coverage expands patient access to advanced rehabilitation technologies.
Key players in the market
Some of the key players in AI-Based Cognitive Rehabilitation Market include Akili Interactive, MedRhythms Inc., Constant Therapy Health, BrainHQ (Posit Science), Cambridge Cognition Holdings plc, Cogstate Ltd., Neuroelectrics, EMOTIV Inc., BrainCo Inc., Philips Healthcare, Siemens Healthineers AG, GE HealthCare, Natus Medical Incorporated, Compumedics Limited, Canon Medical Systems Corporation, FUJIFILM Healthcare and Kernel Inc..
Key Developments:
In June 2026, Akili Interactive launched an expanded cognitive rehabilitation platform for adult stroke patients featuring adaptive AI algorithms that personalize exercise difficulty based on real-time performance metrics.
In May 2026, MedRhythms Inc. secured FDA breakthrough device designation for its rhythmic auditory stimulation system that uses AI to optimize motor-cognitive rehabilitation protocols for traumatic brain injury patients.
In April 2026, Constant Therapy Health introduced a cloud-based cognitive rehabilitation solution enabling remote therapist oversight of patient home exercises with automated progress reporting and intervention adjustment capabilities.
Solution Types Covered:
All the customers of this report will be entitled to receive one of the following free customization options:
Market Dynamics:
Driver:
Rising neurological conditions
The rising global incidence of stroke, traumatic brain injury, and dementia is creating substantial demand for AI-based cognitive rehabilitation solutions. Aging populations in developed nations face increasing rates of cognitive impairment that strain traditional healthcare delivery capacity. Healthcare providers seek scalable technologies that extend specialist reach to underserved communities. Regulatory approvals for digital therapeutic interventions in neurological care accelerate clinical adoption. These demographic and systemic pressures generate sustained market expansion across hospital and home care settings.
Restraint:
High implementation costs
The high implementation costs and technical complexity of AI-based cognitive rehabilitation systems create significant barriers for smaller healthcare facilities and resource-constrained markets. Clinicians require extensive training to effectively interpret AI-generated assessments and adjust rehabilitation protocols. Integration with existing electronic health record systems remains technically challenging and expensive. These operational hurdles slow deployment timelines and limit market penetration beyond well-funded academic medical centers and specialized rehabilitation institutions.
Opportunity:
Home healthcare expansion
The expansion of home-based healthcare delivery models presents significant growth opportunities for AI-based cognitive rehabilitation providers. Remote monitoring capabilities enable continuous therapy outside clinical settings, improving patient adherence and outcomes while reducing healthcare system costs. Reimbursement frameworks increasingly recognize the value of remote therapeutic monitoring for chronic neurological conditions. Partnerships with home health agencies and family caregiver support programs create distribution channels that extend market reach beyond traditional facilities.
Threat:
Unvalidated alternatives
The emergence of generic cognitive training applications that lack clinical validation threatens to undermine market confidence in AI-based cognitive rehabilitation solutions. Consumer confusion between entertainment-oriented brain games and FDA-cleared therapeutic platforms creates pricing pressure and dilutes clinical credibility. Regulatory scrutiny of health claims for software-based interventions intensifies as the market expands. These factors complicate commercialization efforts for evidence-based rehabilitation technology developers.
Covid-19 Impact:
The COVID-19 pandemic severely disrupted in-person rehabilitation services while accelerating the adoption of remote AI-based cognitive therapy platforms. Hospital capacity constraints and infection control protocols forced the postponement of non-urgent neurological rehabilitation. Telehealth reimbursement expansions enabled the rapid deployment of remote cognitive assessment and training tools. Post-pandemic, hybrid care models that combine in-person and digital rehabilitation sessions have become standard practice.
The AI cognitive therapy platforms segment is expected to be the largest during the forecast period
The AI cognitive therapy platforms segment is expected to account for the largest market share during the forecast period, due to their comprehensive therapeutic capabilities and integration with clinical workflows. These platforms combine assessment, personalized exercise generation, and progress tracking within unified systems that support clinician decision-making. Healthcare institutions prefer all-in-one solutions that reduce technology procurement complexity. Established reimbursement codes for cognitive rehabilitation services further support the adoption of these clinically validated platforms.
The virtual reality segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the virtual reality segment is predicted to witness the highest growth rate, driven by its ability to create immersive, engaging rehabilitation environments that significantly improve patient motivation and adherence compared to traditional exercises. VR systems simulate real-world scenarios for practicing daily living skills in safe, controlled settings. Declining hardware costs and improved accessibility make virtual reality rehabilitation economically viable for broader patient populations. Clinical evidence demonstrating efficacy for stroke and trauma recovery accelerates adoption.
Region with largest share:
During the forecast period, the North America region is expected to hold the largest market share, due to advanced neurological research infrastructure and early regulatory approval pathways for digital therapeutic devices. The United States leads with substantial National Institutes of Health funding for brain injury research and established rehabilitation networks within the Veterans Health Administration. Major academic medical centers pioneer clinical validation studies that generate evidence supporting commercial adoption. Reimbursement frameworks increasingly cover remote therapeutic monitoring services.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapidly aging populations in China and Japan driving demand for neurological rehabilitation services. Government investment in smart healthcare initiatives supports technology adoption across public hospital networks. South Korea and Singapore lead in integrating robotic and virtual reality rehabilitation into standard clinical practice. The region's manufacturing capabilities reduce equipment costs, while growing health insurance coverage expands patient access to advanced rehabilitation technologies.
Key players in the market
Some of the key players in AI-Based Cognitive Rehabilitation Market include Akili Interactive, MedRhythms Inc., Constant Therapy Health, BrainHQ (Posit Science), Cambridge Cognition Holdings plc, Cogstate Ltd., Neuroelectrics, EMOTIV Inc., BrainCo Inc., Philips Healthcare, Siemens Healthineers AG, GE HealthCare, Natus Medical Incorporated, Compumedics Limited, Canon Medical Systems Corporation, FUJIFILM Healthcare and Kernel Inc..
Key Developments:
In June 2026, Akili Interactive launched an expanded cognitive rehabilitation platform for adult stroke patients featuring adaptive AI algorithms that personalize exercise difficulty based on real-time performance metrics.
In May 2026, MedRhythms Inc. secured FDA breakthrough device designation for its rhythmic auditory stimulation system that uses AI to optimize motor-cognitive rehabilitation protocols for traumatic brain injury patients.
In April 2026, Constant Therapy Health introduced a cloud-based cognitive rehabilitation solution enabling remote therapist oversight of patient home exercises with automated progress reporting and intervention adjustment capabilities.
Solution Types Covered:
- AI Cognitive Therapy Platforms
- Digital Rehabilitation Software
- Neurofeedback Systems
- Virtual Reality Rehabilitation
- Robotic Rehabilitation Systems
- Cognitive Assessment Platforms
- Artificial Intelligence
- Machine Learning
- Deep Learning
- Computer Vision
- Natural Language Processing
- Virtual Reality
- Cloud-Based Analytics
- Stroke Rehabilitation
- Traumatic Brain Injury
- Dementia
- Alzheimer's Disease
- Parkinson's Disease
- ADHD
- Other Neurological Disorders
- Hospitals
- Rehabilitation Centers
- Neurology Clinics
- Home Healthcare
- Academic & Research Institutes
- Long-Term Care Facilities
- Other End Users
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
- Rest of the World (RoW)
- Middle East
- Saudi Arabia
- United Arab Emirates
- Qatar
- Israel
- Rest of Middle East
- Africa
- South Africa
- Egypt
- Morocco
- Rest of Africa
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
1 EXECUTIVE SUMMARY
1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations
2 RESEARCH FRAMEWORK
2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
2.4.1 Data Collection (Primary and Secondary)
2.4.2 Data Modeling and Estimation Techniques
2.4.3 Data Validation and Triangulation
2.4.4 Analytical and Forecasting Approach
3 MARKET DYNAMICS AND TREND ANALYSIS
3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook
4 COMPETITIVE AND STRATEGIC ASSESSMENT
4.1 Porter's Five Forces Analysis
4.1.1 Supplier Bargaining Power
4.1.2 Buyer Bargaining Power
4.1.3 Threat of Substitutes
4.1.4 Threat of New Entrants
4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison
5 GLOBAL AI-BASED COGNITIVE REHABILITATION MARKET, BY SOLUTION TYPE
5.1 AI Cognitive Therapy Platforms
5.2 Digital Rehabilitation Software
5.3 Neurofeedback Systems
5.4 Virtual Reality Rehabilitation
5.5 Robotic Rehabilitation Systems
5.6 Cognitive Assessment Platforms
6 GLOBAL AI-BASED COGNITIVE REHABILITATION MARKET, BY TECHNOLOGY
6.1 Artificial Intelligence
6.2 Machine Learning
6.3 Deep Learning
6.4 Computer Vision
6.5 Natural Language Processing
6.6 Virtual Reality
6.7 Cloud-Based Analytics
7 GLOBAL AI-BASED COGNITIVE REHABILITATION MARKET, BY INDICATION
7.1 Stroke Rehabilitation
7.2 Traumatic Brain Injury
7.3 Dementia
7.4 Alzheimer's Disease
7.5 Parkinson's Disease
7.6 ADHD
7.7 Other Neurological Disorders
8 GLOBAL AI-BASED COGNITIVE REHABILITATION MARKET, BY END USER
8.1 Hospitals
8.2 Rehabilitation Centers
8.3 Neurology Clinics
8.4 Home Healthcare
8.5 Academic & Research Institutes
8.6 Long-Term Care Facilities
8.7 Other End Users
9 GLOBAL AI-BASED COGNITIVE REHABILITATION MARKET, BY GEOGRAPHY
9.1 North America
9.1.1 United States
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 United Kingdom
9.2.2 Germany
9.2.3 France
9.2.4 Italy
9.2.5 Spain
9.2.6 Netherlands
9.2.7 Belgium
9.2.8 Sweden
9.2.9 Switzerland
9.2.10 Poland
9.2.11 Rest of Europe
9.3 Asia Pacific
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 South Korea
9.3.5 Australia
9.3.6 Indonesia
9.3.7 Thailand
9.3.8 Malaysia
9.3.9 Singapore
9.3.10 Vietnam
9.3.11 Rest of Asia Pacific
9.4 South America
9.4.1 Brazil
9.4.2 Argentina
9.4.3 Colombia
9.4.4 Chile
9.4.5 Peru
9.4.6 Rest of South America
9.5 Rest of the World (RoW)
9.5.1 Middle East
9.5.1.1 Saudi Arabia
9.5.1.2 United Arab Emirates
9.5.1.3 Qatar
9.5.1.4 Israel
9.5.1.5 Rest of Middle East
9.5.2 Africa
9.5.2.1 South Africa
9.5.2.2 Egypt
9.5.2.3 Morocco
9.5.2.4 Rest of Africa
10 STRATEGIC MARKET INTELLIGENCE
10.1 Industry Value Network and Supply Chain Assessment
10.2 White-Space and Opportunity Mapping
10.3 Product Evolution and Market Life Cycle Analysis
10.4 Channel, Distributor, and Go-to-Market Assessment
11 INDUSTRY DEVELOPMENTS AND STRATEGIC INITIATIVES
11.1 Mergers and Acquisitions
11.2 Partnerships, Alliances, and Joint Ventures
11.3 New Product Launches and Certifications
11.4 Capacity Expansion and Investments
11.5 Other Strategic Initiatives
12 COMPANY PROFILES
12.1 Akili Interactive
12.2 MedRhythms Inc.
12.3 Constant Therapy Health
12.4 BrainHQ (Posit Science)
12.5 Cambridge Cognition Holdings plc
12.6 Cogstate Ltd.
12.7 Neuroelectrics
12.8 EMOTIV Inc.
12.9 BrainCo Inc.
12.10 Philips Healthcare
12.11 Siemens Healthineers AG
12.12 GE HealthCare
12.13 Natus Medical Incorporated
12.14 Compumedics Limited
12.15 Canon Medical Systems Corporation
12.16 FUJIFILM Healthcare
12.17 Kernel Inc.
1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations
2 RESEARCH FRAMEWORK
2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
2.4.1 Data Collection (Primary and Secondary)
2.4.2 Data Modeling and Estimation Techniques
2.4.3 Data Validation and Triangulation
2.4.4 Analytical and Forecasting Approach
3 MARKET DYNAMICS AND TREND ANALYSIS
3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook
4 COMPETITIVE AND STRATEGIC ASSESSMENT
4.1 Porter's Five Forces Analysis
4.1.1 Supplier Bargaining Power
4.1.2 Buyer Bargaining Power
4.1.3 Threat of Substitutes
4.1.4 Threat of New Entrants
4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison
5 GLOBAL AI-BASED COGNITIVE REHABILITATION MARKET, BY SOLUTION TYPE
5.1 AI Cognitive Therapy Platforms
5.2 Digital Rehabilitation Software
5.3 Neurofeedback Systems
5.4 Virtual Reality Rehabilitation
5.5 Robotic Rehabilitation Systems
5.6 Cognitive Assessment Platforms
6 GLOBAL AI-BASED COGNITIVE REHABILITATION MARKET, BY TECHNOLOGY
6.1 Artificial Intelligence
6.2 Machine Learning
6.3 Deep Learning
6.4 Computer Vision
6.5 Natural Language Processing
6.6 Virtual Reality
6.7 Cloud-Based Analytics
7 GLOBAL AI-BASED COGNITIVE REHABILITATION MARKET, BY INDICATION
7.1 Stroke Rehabilitation
7.2 Traumatic Brain Injury
7.3 Dementia
7.4 Alzheimer's Disease
7.5 Parkinson's Disease
7.6 ADHD
7.7 Other Neurological Disorders
8 GLOBAL AI-BASED COGNITIVE REHABILITATION MARKET, BY END USER
8.1 Hospitals
8.2 Rehabilitation Centers
8.3 Neurology Clinics
8.4 Home Healthcare
8.5 Academic & Research Institutes
8.6 Long-Term Care Facilities
8.7 Other End Users
9 GLOBAL AI-BASED COGNITIVE REHABILITATION MARKET, BY GEOGRAPHY
9.1 North America
9.1.1 United States
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 United Kingdom
9.2.2 Germany
9.2.3 France
9.2.4 Italy
9.2.5 Spain
9.2.6 Netherlands
9.2.7 Belgium
9.2.8 Sweden
9.2.9 Switzerland
9.2.10 Poland
9.2.11 Rest of Europe
9.3 Asia Pacific
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 South Korea
9.3.5 Australia
9.3.6 Indonesia
9.3.7 Thailand
9.3.8 Malaysia
9.3.9 Singapore
9.3.10 Vietnam
9.3.11 Rest of Asia Pacific
9.4 South America
9.4.1 Brazil
9.4.2 Argentina
9.4.3 Colombia
9.4.4 Chile
9.4.5 Peru
9.4.6 Rest of South America
9.5 Rest of the World (RoW)
9.5.1 Middle East
9.5.1.1 Saudi Arabia
9.5.1.2 United Arab Emirates
9.5.1.3 Qatar
9.5.1.4 Israel
9.5.1.5 Rest of Middle East
9.5.2 Africa
9.5.2.1 South Africa
9.5.2.2 Egypt
9.5.2.3 Morocco
9.5.2.4 Rest of Africa
10 STRATEGIC MARKET INTELLIGENCE
10.1 Industry Value Network and Supply Chain Assessment
10.2 White-Space and Opportunity Mapping
10.3 Product Evolution and Market Life Cycle Analysis
10.4 Channel, Distributor, and Go-to-Market Assessment
11 INDUSTRY DEVELOPMENTS AND STRATEGIC INITIATIVES
11.1 Mergers and Acquisitions
11.2 Partnerships, Alliances, and Joint Ventures
11.3 New Product Launches and Certifications
11.4 Capacity Expansion and Investments
11.5 Other Strategic Initiatives
12 COMPANY PROFILES
12.1 Akili Interactive
12.2 MedRhythms Inc.
12.3 Constant Therapy Health
12.4 BrainHQ (Posit Science)
12.5 Cambridge Cognition Holdings plc
12.6 Cogstate Ltd.
12.7 Neuroelectrics
12.8 EMOTIV Inc.
12.9 BrainCo Inc.
12.10 Philips Healthcare
12.11 Siemens Healthineers AG
12.12 GE HealthCare
12.13 Natus Medical Incorporated
12.14 Compumedics Limited
12.15 Canon Medical Systems Corporation
12.16 FUJIFILM Healthcare
12.17 Kernel Inc.
LIST OF TABLES
Table 1 Global AI-Based Cognitive Rehabilitation Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global AI-Based Cognitive Rehabilitation Market Outlook, By Solution Type (2023-2034) ($MN)
Table 3 Global AI-Based Cognitive Rehabilitation Market Outlook, By AI Cognitive Therapy Platforms (2023-2034) ($MN)
Table 4 Global AI-Based Cognitive Rehabilitation Market Outlook, By Digital Rehabilitation Software (2023-2034) ($MN)
Table 5 Global AI-Based Cognitive Rehabilitation Market Outlook, By Neurofeedback Systems (2023-2034) ($MN)
Table 6 Global AI-Based Cognitive Rehabilitation Market Outlook, By Virtual Reality Rehabilitation (2023-2034) ($MN)
Table 7 Global AI-Based Cognitive Rehabilitation Market Outlook, By Robotic Rehabilitation Systems (2023-2034) ($MN)
Table 8 Global AI-Based Cognitive Rehabilitation Market Outlook, By Cognitive Assessment Platforms (2023-2034) ($MN)
Table 9 Global AI-Based Cognitive Rehabilitation Market Outlook, By Technology (2023-2034) ($MN)
Table 10 Global AI-Based Cognitive Rehabilitation Market Outlook, By Artificial Intelligence (2023-2034) ($MN)
Table 11 Global AI-Based Cognitive Rehabilitation Market Outlook, By Machine Learning (2023-2034) ($MN)
Table 12 Global AI-Based Cognitive Rehabilitation Market Outlook, By Deep Learning (2023-2034) ($MN)
Table 13 Global AI-Based Cognitive Rehabilitation Market Outlook, By Computer Vision (2023-2034) ($MN)
Table 14 Global AI-Based Cognitive Rehabilitation Market Outlook, By Natural Language Processing (2023-2034) ($MN)
Table 15 Global AI-Based Cognitive Rehabilitation Market Outlook, By Virtual Reality (2023-2034) ($MN)
Table 16 Global AI-Based Cognitive Rehabilitation Market Outlook, By Cloud-Based Analytics (2023-2034) ($MN)
Table 17 Global AI-Based Cognitive Rehabilitation Market Outlook, By Indication (2023-2034) ($MN)
Table 18 Global AI-Based Cognitive Rehabilitation Market Outlook, By Stroke Rehabilitation (2023-2034) ($MN)
Table 19 Global AI-Based Cognitive Rehabilitation Market Outlook, By Traumatic Brain Injury (2023-2034) ($MN)
Table 20 Global AI-Based Cognitive Rehabilitation Market Outlook, By Dementia (2023-2034) ($MN)
Table 21 Global AI-Based Cognitive Rehabilitation Market Outlook, By Alzheimer's Disease (2023-2034) ($MN)
Table 22 Global AI-Based Cognitive Rehabilitation Market Outlook, By Parkinson's Disease (2023-2034) ($MN)
Table 23 Global AI-Based Cognitive Rehabilitation Market Outlook, By ADHD (2023-2034) ($MN)
Table 24 Global AI-Based Cognitive Rehabilitation Market Outlook, By Other Neurological Disorders (2023-2034) ($MN)
Table 25 Global AI-Based Cognitive Rehabilitation Market Outlook, By End User (2023-2034) ($MN)
Table 26 Global AI-Based Cognitive Rehabilitation Market Outlook, By Hospitals (2023-2034) ($MN)
Table 27 Global AI-Based Cognitive Rehabilitation Market Outlook, By Rehabilitation Centers (2023-2034) ($MN)
Table 28 Global AI-Based Cognitive Rehabilitation Market Outlook, By Neurology Clinics (2023-2034) ($MN)
Table 29 Global AI-Based Cognitive Rehabilitation Market Outlook, By Home Healthcare (2023-2034) ($MN)
Table 30 Global AI-Based Cognitive Rehabilitation Market Outlook, By Academic & Research Institutes (2023-2034) ($MN)
Table 31 Global AI-Based Cognitive Rehabilitation Market Outlook, By Long-Term Care Facilities (2023-2034) ($MN)
Table 32 Global AI-Based Cognitive Rehabilitation Market Outlook, By Other End Users (2023-2034) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.
Table 1 Global AI-Based Cognitive Rehabilitation Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global AI-Based Cognitive Rehabilitation Market Outlook, By Solution Type (2023-2034) ($MN)
Table 3 Global AI-Based Cognitive Rehabilitation Market Outlook, By AI Cognitive Therapy Platforms (2023-2034) ($MN)
Table 4 Global AI-Based Cognitive Rehabilitation Market Outlook, By Digital Rehabilitation Software (2023-2034) ($MN)
Table 5 Global AI-Based Cognitive Rehabilitation Market Outlook, By Neurofeedback Systems (2023-2034) ($MN)
Table 6 Global AI-Based Cognitive Rehabilitation Market Outlook, By Virtual Reality Rehabilitation (2023-2034) ($MN)
Table 7 Global AI-Based Cognitive Rehabilitation Market Outlook, By Robotic Rehabilitation Systems (2023-2034) ($MN)
Table 8 Global AI-Based Cognitive Rehabilitation Market Outlook, By Cognitive Assessment Platforms (2023-2034) ($MN)
Table 9 Global AI-Based Cognitive Rehabilitation Market Outlook, By Technology (2023-2034) ($MN)
Table 10 Global AI-Based Cognitive Rehabilitation Market Outlook, By Artificial Intelligence (2023-2034) ($MN)
Table 11 Global AI-Based Cognitive Rehabilitation Market Outlook, By Machine Learning (2023-2034) ($MN)
Table 12 Global AI-Based Cognitive Rehabilitation Market Outlook, By Deep Learning (2023-2034) ($MN)
Table 13 Global AI-Based Cognitive Rehabilitation Market Outlook, By Computer Vision (2023-2034) ($MN)
Table 14 Global AI-Based Cognitive Rehabilitation Market Outlook, By Natural Language Processing (2023-2034) ($MN)
Table 15 Global AI-Based Cognitive Rehabilitation Market Outlook, By Virtual Reality (2023-2034) ($MN)
Table 16 Global AI-Based Cognitive Rehabilitation Market Outlook, By Cloud-Based Analytics (2023-2034) ($MN)
Table 17 Global AI-Based Cognitive Rehabilitation Market Outlook, By Indication (2023-2034) ($MN)
Table 18 Global AI-Based Cognitive Rehabilitation Market Outlook, By Stroke Rehabilitation (2023-2034) ($MN)
Table 19 Global AI-Based Cognitive Rehabilitation Market Outlook, By Traumatic Brain Injury (2023-2034) ($MN)
Table 20 Global AI-Based Cognitive Rehabilitation Market Outlook, By Dementia (2023-2034) ($MN)
Table 21 Global AI-Based Cognitive Rehabilitation Market Outlook, By Alzheimer's Disease (2023-2034) ($MN)
Table 22 Global AI-Based Cognitive Rehabilitation Market Outlook, By Parkinson's Disease (2023-2034) ($MN)
Table 23 Global AI-Based Cognitive Rehabilitation Market Outlook, By ADHD (2023-2034) ($MN)
Table 24 Global AI-Based Cognitive Rehabilitation Market Outlook, By Other Neurological Disorders (2023-2034) ($MN)
Table 25 Global AI-Based Cognitive Rehabilitation Market Outlook, By End User (2023-2034) ($MN)
Table 26 Global AI-Based Cognitive Rehabilitation Market Outlook, By Hospitals (2023-2034) ($MN)
Table 27 Global AI-Based Cognitive Rehabilitation Market Outlook, By Rehabilitation Centers (2023-2034) ($MN)
Table 28 Global AI-Based Cognitive Rehabilitation Market Outlook, By Neurology Clinics (2023-2034) ($MN)
Table 29 Global AI-Based Cognitive Rehabilitation Market Outlook, By Home Healthcare (2023-2034) ($MN)
Table 30 Global AI-Based Cognitive Rehabilitation Market Outlook, By Academic & Research Institutes (2023-2034) ($MN)
Table 31 Global AI-Based Cognitive Rehabilitation Market Outlook, By Long-Term Care Facilities (2023-2034) ($MN)
Table 32 Global AI-Based Cognitive Rehabilitation Market Outlook, By Other End Users (2023-2034) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.
